He and his team have been awarded one of the Foundation’s General Operating Grants, receiving $70,000 to study if a newly developed antioxidant protein can decrease cell death and improve stem cell response in brain tissue of patients recovering from stroke, ultimately improving patient recovery. Technology and expertise in HSC’s Kleysen Institute for Advanced Medicine will enable Dr. Eftekharpour and his team to view and assess the cells with state-of-the-art imaging techniques.